BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23030396)

  • 1. Usefulness of Ki-67 (MIB-1) immunostaining in the diagnosis of pulmonary sclerosing hemangiomas.
    Kim BH; Bae YS; Kim SH; Jeong HJ; Hong SW; Yoon SO
    APMIS; 2013 Feb; 121(2):105-10. PubMed ID: 23030396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological analysis of pulmonary sclerosing hemangioma.
    Iyoda A; Hiroshima K; Shiba M; Haga Y; Moriya Y; Sekine Y; Shibuya K; Iizasa T; Fujisawa T
    Ann Thorac Surg; 2004 Dec; 78(6):1928-31. PubMed ID: 15561002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell proliferation correlates with prognosis in acinic cell carcinomas of salivary gland origin. Immunohistochemical study of 30 cases using the MIB 1 antibody in formalin-fixed paraffin sections.
    Skalova A; Leivo I; Von Boguslawsky K; Saksela E
    J Pathol; 1994 May; 173(1):13-21. PubMed ID: 7931834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonary sclerosing hemangioma: report of 15 cases and review of the literature].
    Gao BL; Hu JA; Wan HY; Chen ZY; Wu HC
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Mar; 29(3):164-6. PubMed ID: 16677478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract.
    Chowdhury GM; Kojima K; Kanayama H; Tsuji M; Kurokawa Y; Kagawa S
    Cancer; 1996 Aug; 78(4):827-33. PubMed ID: 8756378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and surgical treatment of pulmonary sclerosing hemangioma].
    Feng FY; Cheng GY; Gao SG; Liu XY; Mao YS; Tan FW; Qiu B; Li N; Li F; He J
    Zhonghua Yi Xue Za Zhi; 2012 May; 92(17):1190-3. PubMed ID: 22883008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.
    Cattoretti G; Becker MH; Key G; Duchrow M; Schlüter C; Galle J; Gerdes J
    J Pathol; 1992 Dec; 168(4):357-63. PubMed ID: 1484317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
    Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
    Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.
    Veronese SM; Maisano C; Scibilia J
    Anticancer Res; 1995; 15(6B):2717-22. PubMed ID: 8669852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and therapeutics of 24 cases of pulmonary sclerosing hemangioma].
    Situ DR; Long H; Ma GW; Lin ZC; Yun JP; Rong TH
    Ai Zheng; 2008 Aug; 27(8):861-5. PubMed ID: 18710622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
    Cina SJ; Richardson MS; Austin RM; Kurman RJ
    Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of matrix metalloproteinase 9 and tubulin-alpha in pulmonary sclerosing hemangioma.
    Cho SJ; Jin LJ; Kim BY; Cho SI; Jung WY; Han JH; Ha SY; Kim HK; Kim A
    Oncol Rep; 2007 Nov; 18(5):1139-44. PubMed ID: 17914564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
    Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
    Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgery treatment for pulmonary sclerosing hemangioma].
    Xie D; Jiang GN; Chen XF; Xu ZF; You XF; Ding JA
    Zhonghua Wai Ke Za Zhi; 2012 Feb; 50(2):120-3. PubMed ID: 22490348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
    Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
    Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship of MAGE-A1 expression with Ki-67 and tumor-infiltrating lymphocyte response in non-small cell lung carcinoma].
    Yue JQ; Diao LM; Li BY; Zou ZY; Xiao J; Chen DP; Fan LF; Guan J
    Ai Zheng; 2004 Feb; 23(2):219-22. PubMed ID: 14960250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
    Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
    Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIB 1 immunostaining in stage I squamous cervical carcinoma: relationship with natural killer cell activity.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; de Nictolis M; Muzzioli M; Fabris N; Romanini C; Biagini G
    Gynecol Oncol; 1995 Jul; 58(1):28-33. PubMed ID: 7789886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical markers in the morphological diagnosis of lung carcinoma.
    Cornianu M; Tudose N
    Rom J Morphol Embryol; 1997; 43(3-4):181-91. PubMed ID: 9747120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.